| Integrative analysis of 111 reference human epigenomes Roadmap Epigenomics Consortium Integrative analysis coordination Kundaje ... Nature 518 (7539), 317-330, 2015 | 6414* | 2015 |
| Malignant astrocytic glioma: genetics, biology, and paths to treatment FB Furnari, T Fenton, RM Bachoo, A Mukasa, JM Stommel, A Stegh, ... Genes & development 21 (21), 2683-2710, 2007 | 2987 | 2007 |
| An integrative model of cellular states, plasticity, and genetics for glioblastoma C Neftel, J Laffy, MG Filbin, T Hara, ME Shore, GJ Rahme, AR Richman, ... Cell 178 (4), 835-849. e21, 2019 | 2118 | 2019 |
| Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial DB Keskin, AJ Anandappa, J Sun, I Tirosh, ND Mathewson, S Li, ... Nature 565 (7738), 234-239, 2019 | 1293 | 2019 |
| Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies JM Stommel, AC Kimmelman, H Ying, R Nabioullin, AH Ponugoti, ... Science 318 (5848), 287-290, 2007 | 1131 | 2007 |
| p16INK4a induces an age-dependent decline in islet regenerative potential J Krishnamurthy, MR Ramsey, KL Ligon, C Torrice, A Koh, S Bonner-Weir, ... Nature 443 (7110), 453-457, 2006 | 1118 | 2006 |
| Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets PK Brastianos, SL Carter, S Santagata, DP Cahill, A Taylor-Weiner, ... Cancer discovery 5 (11), 1164-1177, 2015 | 1096 | 2015 |
| p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation H Zheng, H Ying, H Yan, AC Kimmelman, DJ Hiller, AJ Chen, SR Perry, ... Nature 455 (7216), 1129-1133, 2008 | 889 | 2008 |
| Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome YJ Cho, A Tsherniak, P Tamayo, S Santagata, A Ligon, H Greulich, ... Journal of clinical oncology 29 (11), 1424-1430, 2011 | 875 | 2011 |
| Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation P Koivunen, S Lee, CG Duncan, G Lopez, G Lu, S Ramkissoon, ... Nature 483 (7390), 484-488, 2012 | 856 | 2012 |
| Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma DTW Jones, B Hutter, N Jäger, A Korshunov, M Kool, HJ Warnatz, ... Nature genetics 45 (8), 927-932, 2013 | 855 | 2013 |
| Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis RM Bachoo, EA Maher, KL Ligon, NE Sharpless, SS Chan, MJ You, ... Cancer cell 1 (3), 269-277, 2002 | 851 | 2002 |
| Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma U Schüller, VM Heine, J Mao, AT Kho, AK Dillon, YG Han, E Huillard, ... Cancer cell 14 (2), 123-134, 2008 | 747 | 2008 |
| Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations PK Brastianos, PM Horowitz, S Santagata, RT Jones, A McKenna, G Getz, ... Nature genetics 45 (3), 285-289, 2013 | 710 | 2013 |
| Emerging insights into the molecular and cellular basis of glioblastoma GP Dunn, ML Rinne, J Wykosky, G Genovese, SN Quayle, IF Dunn, ... Genes & development 26 (8), 756-784, 2012 | 689 | 2012 |
| Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq MG Filbin, I Tirosh, V Hovestadt, MKL Shaw, LE Escalante, ... Science 360 (6386), 331-335, 2018 | 637 | 2018 |
| Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination B Emery, D Agalliu, JD Cahoy, TA Watkins, JC Dugas, SB Mulinyawe, ... Cell 138 (1), 172-185, 2009 | 615 | 2009 |
| Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma KL Ligon, E Huillard, S Mehta, S Kesari, H Liu, JA Alberta, RM Bachoo, ... Neuron 53 (4), 503-517, 2007 | 601 | 2007 |
| Targetable genetic features of primary testicular and primary central nervous system lymphomas B Chapuy, MGM Roemer, C Stewart, Y Tan, RP Abo, L Zhang, AJ Dunford, ... Blood, The Journal of the American Society of Hematology 127 (7), 869-881, 2016 | 583 | 2016 |
| Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study N Butowski, H Colman, JF De Groot, AM Omuro, L Nayak, PY Wen, ... Neuro-oncology 18 (4), 557-564, 2015 | 570 | 2015 |
Sandro Santagata MD PhDBWH Pathology | HMS Laboratory of Systems Pharmacology | HMS Department of SysBioยืนยันอีเมลแล้วที่ bics.bwh.harvard.edu